General Info
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Location: Cambridge
Country:
Industries:
Investment Regions:
Investment Stages: late-stage
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Search found Biogen acquisition activity in 2025: Biogen announced it entered into definitive agreement to acquire Alcyone Therapeutics with press releases dated Sep 18-19, 2025 – an investment/acquisition within 3 months of the evaluation date. The startup involved is Alcyone Therapeutics. The time difference from that transaction places Biogen in the category corresponding to an investment less than 3 months ago.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Biogen
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI